Article Details
Retrieved on: 2018-01-18 14:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Renaissance Technologies</b> LLC increased its position in OHR Pharmaceutical by 242.3% in the first quarter. <b>Renaissance Technologies</b> LLC now owns 229,709 shares of the biotechnology company's stock worth $191,000 after buying an additional 162,600 shares in the last quarter. Cannell Peter B ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here